Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 20:00
Onconetix Total Liabilities (Quarterly): 88.19M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 88.19M |
| March 31, 2024 | 89.53M |
| December 31, 2023 | 86.11M |
| September 30, 2023 | 17.65M |
| June 30, 2023 | 16.67M |
| March 31, 2023 | 2.809M |
| December 31, 2022 | 3.922M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.431M |
| June 30, 2022 | 3.059M |
| March 31, 2022 | 2.801M |
| December 31, 2021 | 1.638M |
| September 30, 2021 | 0.796M |
| December 31, 2020 | 0.0783M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0783M
Minimum
Dec 2020
89.53M
Maximum
Mar 2024
24.44M
Average
3.922M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.46M |
| Shareholders Equity (Quarterly) | -35.81M |
| Debt to Equity Ratio | -0.4216 |
| Current Ratio | 0.0988 |